Cargando…
Effectiveness of hemoperfusion (HP) in hemodialysis (HD) patients with Covid-19 infection
INTRODUCTION: The aims of this study are to observe the clinical course of all patients affected by infection with SARS-CoV-2 undergoing HD focusing on the impact of HP. METHODS: Patients were divided into Group A: HD sessions with HP and Group B: patients without HP. We registered all the data rega...
Autor principal: | Griveas, Ioannis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616508/ https://www.ncbi.nlm.nih.gov/pubmed/36376212 http://dx.doi.org/10.1016/j.transci.2022.103589 |
Ejemplares similares
-
WITHDRAWN: Soluble urokinase plasminogen activator
receptor and its complicated role in hemodialysis (HD) patients with Covid-19
infection
por: Griveas, Ioannis, et al.
Publicado: (2022) -
Combined Hemoperfusion and Hemodialysis Treatment of Poisoning with Cholinesterase Inhibitors
por: Durakovic, Zijad
Publicado: (1993) -
Apheresis and Covid-19
por: Griveas, Ioannis
Publicado: (2022) -
Two cases of ceftriaxone‐induced encephalopathy treated by hemoperfusion in hemodialysis patients
por: Onogi, Chikao, et al.
Publicado: (2022) -
Immunoadsorption and covid 19 pandemic
por: Tseke, Paraskevi, et al.
Publicado: (2022)